IL123333A - 1R (Alec) ilaimidazoline - 2 lozenges, their preparation and pharmaceuticals containing - Google Patents

1R (Alec) ilaimidazoline - 2 lozenges, their preparation and pharmaceuticals containing

Info

Publication number
IL123333A
IL123333A IL12333396A IL12333396A IL123333A IL 123333 A IL123333 A IL 123333A IL 12333396 A IL12333396 A IL 12333396A IL 12333396 A IL12333396 A IL 12333396A IL 123333 A IL123333 A IL 123333A
Authority
IL
Israel
Prior art keywords
morpholinoimidazolin
chlorophenyl
compounds
general formula
alkyl
Prior art date
Application number
IL12333396A
Other languages
English (en)
Hebrew (he)
Other versions
IL123333A0 (en
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL123333(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of IL123333A0 publication Critical patent/IL123333A0/xx
Publication of IL123333A publication Critical patent/IL123333A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL12333396A 1995-09-05 1996-07-26 1R (Alec) ilaimidazoline - 2 lozenges, their preparation and pharmaceuticals containing IL123333A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (de) 1995-09-05 1995-09-05 Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
PCT/EP1996/003295 WO1997009314A1 (de) 1995-09-05 1996-07-26 Neue, antikonvulsiv wirkende 1-ar(alk)yl-imidazolin-2-one, die in 4-stellung einen disubstituierten amin-rest enthalten, und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
IL123333A0 IL123333A0 (en) 1998-09-24
IL123333A true IL123333A (en) 2001-10-31

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12333396A IL123333A (en) 1995-09-05 1996-07-26 1R (Alec) ilaimidazoline - 2 lozenges, their preparation and pharmaceuticals containing

Country Status (31)

Country Link
EP (1) EP0863880B1 (cs)
JP (1) JP4030578B2 (cs)
CN (1) CN1103762C (cs)
AR (1) AR003502A1 (cs)
AT (1) ATE254606T1 (cs)
AU (1) AU700602B2 (cs)
BG (1) BG63917B1 (cs)
BR (1) BR9610359A (cs)
CA (1) CA2184871C (cs)
CZ (1) CZ291839B6 (cs)
DE (2) DE19532668A1 (cs)
DK (1) DK0863880T3 (cs)
EA (1) EA000535B1 (cs)
EE (1) EE03562B1 (cs)
ES (1) ES2208758T3 (cs)
FR (1) FR13C0049I2 (cs)
GE (1) GEP20022652B (cs)
HU (1) HU225956B1 (cs)
IL (1) IL123333A (cs)
LT (1) LT4482B (cs)
LU (1) LU92263I2 (cs)
NO (1) NO313829B1 (cs)
NZ (1) NZ315624A (cs)
PL (1) PL188287B1 (cs)
PT (1) PT863880E (cs)
SK (1) SK284868B6 (cs)
TR (1) TR199800476T1 (cs)
TW (1) TW422838B (cs)
UA (1) UA46790C2 (cs)
WO (1) WO1997009314A1 (cs)
ZA (1) ZA967014B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (de) * 1997-05-23 1998-11-26 Dresden Arzneimittel Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
CN101254189A (zh) * 2003-07-11 2008-09-03 埃尔比昂股份公司 用对苯并二氮杂䓬受体的α3亚基具有选择性的化合物治疗或预防中枢神经系统病症的方法
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
JP2014521714A (ja) 2011-08-12 2014-08-28 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング ネコ科動物の心不全を治療および予防する方法において使用するための奇異性電流（Ｉｆ）阻害薬
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina
EP4553066A1 (en) 2023-11-10 2025-05-14 Justesa Imagen S.A.U. Improved process for the synthesis of imepitoin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
BE790380A (fr) 1971-10-21 1973-04-20 American Cyanamid Co Nouvelles (p-chloro) phenyl-1 methyl-3 imidazolidines, 2,4-disubstituees utiles notamment comme agents diuretiques antialdosterone et leur procede de preparation
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
MX9801742A (es) 1998-08-30
BG102287A (en) 1998-09-30
EE9800063A (et) 1998-08-17
CA2184871C (en) 2001-08-21
EP0863880A1 (de) 1998-09-16
WO1997009314A1 (de) 1997-03-13
PL325413A1 (en) 1998-07-20
EA000535B1 (ru) 1999-10-28
HUP9802941A3 (en) 1999-10-28
GEP20022652B (en) 2002-03-25
TW422838B (en) 2001-02-21
HU225956B1 (en) 2008-01-28
JPH11512101A (ja) 1999-10-19
BR9610359A (pt) 1999-07-06
UA46790C2 (uk) 2002-06-17
CZ291839B6 (cs) 2003-06-18
PL188287B1 (pl) 2005-01-31
CZ66198A3 (cs) 1998-07-15
JP4030578B2 (ja) 2008-01-09
ZA967014B (en) 1997-08-18
SK21698A3 (en) 1998-10-07
CN1200728A (zh) 1998-12-02
EA199800271A1 (ru) 1998-10-29
LT4482B (lt) 1999-03-25
AU700602B2 (en) 1999-01-07
NO980906L (no) 1998-03-02
LU92263I2 (fr) 2013-10-07
FR13C0049I2 (fr) 2014-03-28
TR199800476T1 (xx) 1998-06-22
EE03562B1 (et) 2001-12-17
DE19532668A1 (de) 1997-03-06
LT98047A (en) 1998-10-26
NO980906D0 (no) 1998-03-02
EP0863880B1 (de) 2003-11-19
DK0863880T3 (da) 2004-03-22
CN1103762C (zh) 2003-03-26
AU6737596A (en) 1997-03-27
ES2208758T3 (es) 2004-06-16
AR003502A1 (es) 1998-08-05
CA2184871A1 (en) 1997-03-06
NO313829B1 (no) 2002-12-09
NZ315624A (en) 1998-11-25
HUP9802941A2 (hu) 1999-09-28
DE59610827D1 (de) 2003-12-24
FR13C0049I1 (cs) 2013-09-27
BG63917B1 (bg) 2003-06-30
PT863880E (pt) 2004-04-30
HK1015776A1 (en) 1999-10-22
IL123333A0 (en) 1998-09-24
ATE254606T1 (de) 2003-12-15
SK284868B6 (sk) 2006-01-05

Similar Documents

Publication Publication Date Title
FI88390B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-aminoalkyl-1,2-benzotiazol-3(2h)-on-1,1-dioxidderivat
IL123333A (en) 1R (Alec) ilaimidazoline - 2 lozenges, their preparation and pharmaceuticals containing
IE904719A1 (en) Derivatives of 2-Aminopyrimidine-4-carboxamide, their preparation and therapeutic use
CH641757A5 (en) O-Alkylated hydroxylamines and process for the preparation thereof
Pavia et al. N, N-Disubstituted 6-alkoxy-2-pyridinamines as anticonvulsant agents
US3941883A (en) Aromatic dicarboxamides as anticonvulsants
FR2680172A1 (fr) Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
AU609415B2 (en) New phenyl, pyrrolidin-2-yl substituted 5-ring heterocycles having antiphycsotic properties
CH627452A5 (en) Process for the preparation of 2,6-disubstituted 2-phenyliminoimidazolidines and their acid addition salts
US5869481A (en) Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making
SU1402251A3 (ru) Способ получени производных 3-фенил-2-пропенамина в виде геометрических изомеров или их смесей, а также фармакологически приемлемых солей
KR910003711B1 (ko) 2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법
HU189671B (en) Process for preparing 5,6-dihydro-11h-dibenzo/b,e/azepin-6-one derivatives
ZA200100999B (en) New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same.
MXPA98001742A (en) New 1-ar (alqu) il-imidazolin-2-onas, which are conposition 4, contains a rested amino resort, of anticonvulsive effect and procedures for suelaborac
HK1015776B (en) Novel 1-ar(alk)ylimidazolin-2-ones containing a disubstituted amine radical in the 4-position, having an anticonvulsive activity, and process for their preparation
EP0213571A2 (de) 3-Aminomethylpyrrol-1-yl-alkylamine und diese Verbindungen enthaltende therapeutische Mittel
FI56831C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrrolidyliden- piperidyliden- och hexahydroazepinyliden-urinaemnen
US4095023A (en) 6-methoxy-n-vanillylidene-4-chromanamine
FI57746C (fi) Foerfarande foer framstaellning av icketoxiska syraadditionssalter av 1-bensyl-2,2-dimetylguanidin och 1-fenetyl-2,3-dimetylguanidin vilka anvaendes foer behandling av hjaertrytmstoerningar
US4113743A (en) 2-[[6-Methoxy-(3,4-dihydro-2H-1-benzopyranyl)]amino]-1-phenylpropanol hydrochloride
JP2002513010A (ja) スルホン化２−オキソピペラジンの固体支持合成
JPS62226959A (ja) ピリジン誘導体、それらの製法および向意識、抗うつ、抗パーキンソン病剤
DE3209141A1 (de) O-substituierte phenoxyhydroxypropylamine, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
CS209355B1 (cs) N-(4-[l-naftyloxy]butyI)amíny a spósob ich přípravy

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees
KB Patent renewed
HC Change of name of proprietor(s)

Owner name: ELBION GMBH

Free format text: FORMER NAME:ELBION AG

KB Patent renewed
KB Patent renewed
EXP Patent expired